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Abstract
We measured hepatitis C virus antibody titers in 13 patients with chronic hepatitis C to de-
termine whether titration of hepatitis C virus antibody was useful or not, to predict and evaluate
the efficacy of interferon (IFN) treatment. During administration of IFN, hepatitis C virus titers
declined in all patients. Antibody titers performed before treatment as well as just at the end of
treatment did not correlate with change of the alanine aminotransferase levels during administra-
tion of IFN. Antibody titers declined continuously after treatment in 5 patients with normal alanine
amino-transferase levels for over 6 months after discontinuation of IFN. Antibody titers rose again
in 6 patients whose alanine aminotransferase levels fluctuated after treatment. An exceptional pat-
tern of change occurred in 2 patients whose antibody titers declined continuously although their
alanine aminotransferase levels fluctuated after treatment. Repeated titration of hepatitis C virus
antibody appears to be useful for evaluating the long-term efficacy of IFN treatment.
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